Haemonetics Corp HAE:NYSE

RT Quote | NYSE | USD
Last | 03/03/21 EST
122.22quote price arrow down-3.02 (-2.41%)
Volume
810,084
52 week range
63.41 - 142.11

...

Loading . . .

KEY STATS

  • Open124.61
  • Day High125.57
  • Day Low118.93
  • Prev Close122.22
  • 52 Week High142.11
  • 52 Week High Date02/09/21
  • 52 Week Low63.41
  • 52 Week Low Date03/18/20
  • Market Cap6.211B
  • Shares Out50.82M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta0.55
  • 1 Year % Change12.43

RATIOS/PROFITABILITY

  • EPS (TTM)2.11
  • P/E (TTM)57.89
  • Fwd P/E (NTM)40.73
  • EBITDA (MRQ)213.202M
  • ROE (MRQ)16.72%
  • Revenue (MRQ)883.93M
  • Gross Margin (MRQ)48.62%
  • Net Margin (MRQ)12.23%
  • Debt To Equity (MRQ)43.08%

EVENTS

  • Earnings Date05/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Haemonetics Corp News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company's segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The Company enables plasma collection customers to source from it a range of products necessary for plasma...
Richard Meelia
Chairman
Christopher Simon
President
William Burke
Chief Financial Officer
Anila Lingamneni
Executive Vice President
Michelle Basil J.D.
Executive Vice President
Address
125 SUMMER STREET
Boston, MA
02110
United States